Adenovirus-Mediated Gene Transfer of Interleukin-4 to Corneal Endothelial Cells and Organ Cultured Corneas Leads to High IL-4 Expression
- 30 November 1999
- journal article
- editorial
- Published by Elsevier in Experimental Eye Research
- Vol. 69 (5) , 563-568
- https://doi.org/10.1006/exer.1999.0731
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- TREATMENT WITH INTERLEUKIN-4 PROLONGS ALLOGENEIC NEONATAL HEART GRAFT SURVIVAL BY INDUCING T HELPER 2 RESPONSESTransplantation, 1998
- Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.Journal of Clinical Investigation, 1997
- Promoter Attenuation in Gene Therapy: Interferon-γand Tumor Necrosis Factor-αInhibit Transgene ExpressionHuman Gene Therapy, 1997
- ANTI-CD4 MONOCLONAL ANTIBODY-INDUCED ALLOGRAFT TOLERANCE IN RATS DESPITE PERSISTENCE OF DONOR-REACTIVE T CELLS1Transplantation, 1997
- INTERLEUKIN-4 OR INTERLEUKIN-10 EXPRESSED FROM ADENOVIRUS-TRANSDUCED SYNGENEIC ISLET GRAFTS FAILS TO PREVENT ?? CELL DESTRUCTION IN DIABETIC NOD MICE1Transplantation, 1997
- Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human corneaGene Therapy, 1997
- Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice.The Journal of Experimental Medicine, 1996
- ADENOVIRUS-MEDIATED GENE DELIVERY TO THE CORNEAL ENDOTHELIUM1Transplantation, 1996
- Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.Proceedings of the National Academy of Sciences, 1994
- Cytokines as mediators of organ graft rejection and toleranceCurrent Opinion in Immunology, 1993